1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6362FCACBBD27B4EB85257DA20057B453
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-optimizing-the-managed-markets-function-budgets-and-structures?opendocument
18
19opendocument
2018.205.96.39
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Resource Benchmarks

Optimizing the Managed Markets Function: Budgets and Structures

ID: 5337


Features:

30 Info Graphics

8 Data Graphics

80+ Metrics

3 Narratives


Pages/Slides: 43


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Optimizing the Managed Markets Function: Budgets and Structures"


STUDY OVERVIEW

As the importance of payers has grown, so too has the value of the Managed Markets function within the pharmaceutical industry. With this recognition, organizations are wrestling with what is the appropriate structure and funding level for the Managed Markets function during this period of market change. This benchmarking analysis was designed to provide current benchmarks and insights around the structure and funding of the Managed Markets function.

This study provides industry metrics and insights that can serve as a reference point for sales and managed markets leaders within small and medium-sized companies.

KEY TOPICS

  • Budgets and Headcount
  • Structure
  • Benchmark Participant Demographics

SAMPLE KEY METRICS
  • Budget (excluding salaries) and staffing levels for Managed Markets organization
  • Percentage of Managed Markets budget allocated to sub-functions within organization
  • Annual revenue and products supported by the Managed Markets function
  • Percentage of Managed Markets staff time dedicated to sub-functions of Managed Markets
  • Sub-functions that play a role in US Managed Markets operations
  • Leadership level of sub-function heads supporting Managed Markets
  • Current and ideal ratios of account managers to directors

SAMPLE KEY FINDING
  • When comparing the span of control of area directors to account managers, it is clear that most companies feel they can run leaner than they are currently- with a full additional account manager FTE on average reporting to each area director.


METHODOLOGY

Best Practices, LLC engaged 11 commercial leaders from targeted small and mid-sized companies that align well with one another in terms of size, market position and resource levels. These 11 companies completed online surveys, which were used to identify innovative as well as efficient “outliers” that were also engaged in interviews to expand on their survey responses.

Industries Profiled:
Biotech; Pharmaceutical; Health Care


Companies Profiled:
United Therapeutics; Horizon Pharma; actavis; Purdue Pharma; Actelion; Daiichi Sankyo; Galderma; Upsher-Smith; Jazz Pharmaceuticals; Eisai; Shire

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.